G.ST Antivirals
Series A in 2024
G.ST Antivirals GmbH is a clinical-stage biotechnology company based in Vienna, Austria, founded in 2019. It specializes in developing antiviral therapies and metabolic solutions targeting respiratory viruses that cause common colds and flu infections. The company's innovative approach involves using a host cell-based strategy to create broad-spectrum antivirals. Its lead therapy utilizes 2-deoxyglucose to disrupt the viral exploitation of host cell metabolism, thereby impeding viral replication both in vitro and in vivo, particularly against rhinoviruses. This method aims to starve viruses by interrupting their nutrient supply, offering a novel treatment for patients with viral diseases.
Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.
Sarcura
Seed Round in 2022
Sarcura is an Austrian deep-tech company developing an instrument platform for industrial manufacturing of advanced cell therapies. The platform blends silicon chip technology with microfluidic processing to enable real-time process control and manipulation at the cellular level, supporting autonomous, modular, and automated production. It combines semiconductor-based microfluidics, intelligent batch processing, and a scalable system architecture to reduce costs, boost production capacity, and tailor processes for diverse cell types. Founded in 2019 and based in Hinterstoder, Sarcura aims to enable scalable, patient-specific therapies, including cancer treatments, by delivering a compact, autonomous manufacturing system.
Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.
Ribbon Biolabs
Series A in 2022
Founded in Vienna, Austria in 2018, Ribbon Biolabs specializes in the synthesis and exploration of long DNA molecules. The company sets new standards in molecular biology by developing innovative methods for DNA synthesis, enabling breakthroughs in synthetic biology.
VitreaLab
Seed Round in 2021
VitreaLab develops laser-powered photonic backlighting technology for displays. The company designs and manufactures photonic integrated circuits and light sources that replace conventional LCD backlighting, delivering dedicated light per sub-pixel with precise color, polarization, and angular distribution. Its approach uses glass-based waveguides to control and route light at microscopic scales, enabling higher energy efficiency, improved brightness and contrast, and richer color rendering. The core objective is to unlock augmented reality, virtual reality, and 3D displays by delivering laser-powered illumination without goggles. Founded in 2018 and headquartered in Vienna, VitreaLab focuses on transforming display technology for everyday use.
contextflow
Series A in 2021
contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.
Sarcura
Seed Round in 2020
Sarcura is an Austrian deep-tech company developing an instrument platform for industrial manufacturing of advanced cell therapies. The platform blends silicon chip technology with microfluidic processing to enable real-time process control and manipulation at the cellular level, supporting autonomous, modular, and automated production. It combines semiconductor-based microfluidics, intelligent batch processing, and a scalable system architecture to reduce costs, boost production capacity, and tailor processes for diverse cell types. Founded in 2019 and based in Hinterstoder, Sarcura aims to enable scalable, patient-specific therapies, including cancer treatments, by delivering a compact, autonomous manufacturing system.
Prewave
Seed Round in 2020
Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.
G.ST Antivirals
Series A in 2020
G.ST Antivirals GmbH is a clinical-stage biotechnology company based in Vienna, Austria, founded in 2019. It specializes in developing antiviral therapies and metabolic solutions targeting respiratory viruses that cause common colds and flu infections. The company's innovative approach involves using a host cell-based strategy to create broad-spectrum antivirals. Its lead therapy utilizes 2-deoxyglucose to disrupt the viral exploitation of host cell metabolism, thereby impeding viral replication both in vitro and in vivo, particularly against rhinoviruses. This method aims to starve viruses by interrupting their nutrient supply, offering a novel treatment for patients with viral diseases.
VitreaLab
Pre Seed Round in 2019
VitreaLab develops laser-powered photonic backlighting technology for displays. The company designs and manufactures photonic integrated circuits and light sources that replace conventional LCD backlighting, delivering dedicated light per sub-pixel with precise color, polarization, and angular distribution. Its approach uses glass-based waveguides to control and route light at microscopic scales, enabling higher energy efficiency, improved brightness and contrast, and richer color rendering. The core objective is to unlock augmented reality, virtual reality, and 3D displays by delivering laser-powered illumination without goggles. Founded in 2018 and headquartered in Vienna, VitreaLab focuses on transforming display technology for everyday use.
Ribbon Biolabs
Seed Round in 2019
Founded in Vienna, Austria in 2018, Ribbon Biolabs specializes in the synthesis and exploration of long DNA molecules. The company sets new standards in molecular biology by developing innovative methods for DNA synthesis, enabling breakthroughs in synthetic biology.
Prewave
Pre Seed Round in 2018
Prewave GmbH is a technology company based in Vienna, Austria, founded in 2017. It specializes in developing a data analytics platform that utilizes machine learning to predict risks in supply chain networks. By analyzing social media data, Prewave's solution monitors and communicates potential supply chain anomalies, allowing businesses to anticipate upcoming risk events and address sustainability challenges. The company's innovative approach enables organizations to enhance their logistics management and mitigate disruptions through timely and informed decision-making.
contextflow
Seed Round in 2018
contextflow develops AI-based solutions for radiology image search and analysis. Its flagship product is a 3D image-based search engine that delivers summary of clinical findings, similar reference cases, and relevant diagnosis support for radiologists. The company partners with healthcare institutions and pharmaceutical companies to enhance patient care.